Global Pharmaceuticals Wholesale and Distribution Market 2023-2027

Description

List of Tables

The pharmaceuticals wholesale and distribution market is forecasted to grow by USD 776.32 bn during 2022-2027, accelerating at a CAGR of 8.92% during the forecast period. The report on the pharmaceuticals wholesale and distribution market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing global pharmaceutical sales, increasing government initiatives for pharmaceutical products, and rising seaborne pharmaceutical transportation.

Technavio's pharmaceuticals wholesale and distribution market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	7.89%
CAGR	8.92%
Incremental Value	$776.32bn

By Type

Branded drugs
Generic drugs

By End-user

Retail pharmacies
Hospital pharmacies
Others

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the emergence of drones in pharmaceuticals wholesale and distribution as one of the prime reasons driving the pharmaceuticals wholesale and distribution market growth during the next few years. Also, strategic partnerships and acquisitions among vendors and increasing incorporation of digital technologies in pharmaceuticals wholesale and distribution solutions will lead to sizable demand in the market.

The report on the pharmaceuticals wholesale and distribution market covers the following areas:

Pharmaceuticals wholesale and distribution market sizing
Pharmaceuticals wholesale and distribution market forecast
Pharmaceuticals wholesale and distribution market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceuticals wholesale and distribution market vendors that include A.F. Hauser Pharmaceutical Inc., Alfresa Holdings Corp., AmerisourceBergen Corp., Attain Med Inc., Cardinal Health Inc., China Resources Pharmaceutical Group Ltd., Dakota Drug Inc., FFF Enterprises Inc., J M Smith Corp., McKesson Corp., Medipal Holdings Corp., Medline Industries LP, Morris and Dickson Co. LLC, Mutual Drug, Owens and Minor Inc., PHOENIX Pharmahandel GmbH and Co KG, Shanghai Fosun Pharmaceutical Group Co. Ltd., Sinopharm Group Co. Ltd., SUZUKEN Co. Ltd., and The Cigna Group. Also, the pharmaceuticals wholesale and distribution market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR70680

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global pharmaceuticals wholesale and distribution market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global pharmaceuticals wholesale and distribution market 2017 - 2021 ($ billion)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.3 End-User Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-User Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Branded drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Branded drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Branded drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Branded drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Branded drugs - Year-over-year growth 2022-2027 (%)
6.4 Generic drugs - Market size and forecast 2022-2027
Exhibit 38: Chart on Generic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Generic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Generic drugs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Generic drugs - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ billion)
Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 48: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 50: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
7.4 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 52: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ billion)
Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 A.F. Hauser Pharmaceutical Inc.
Exhibit 111: A.F. Hauser Pharmaceutical Inc. - Overview
Exhibit 112: A.F. Hauser Pharmaceutical Inc. - Product / Service
Exhibit 113: A.F. Hauser Pharmaceutical Inc. - Key offerings
12.4 Alfresa Holdings Corp.
Exhibit 114: Alfresa Holdings Corp. - Overview
Exhibit 115: Alfresa Holdings Corp. - Business segments
Exhibit 116: Alfresa Holdings Corp. - Key news
Exhibit 117: Alfresa Holdings Corp. - Key offerings
Exhibit 118: Alfresa Holdings Corp. - Segment focus
12.5 AmerisourceBergen Corp.
Exhibit 119: AmerisourceBergen Corp. - Overview
Exhibit 120: AmerisourceBergen Corp. - Business segments
Exhibit 121: AmerisourceBergen Corp. - Key offerings
Exhibit 122: AmerisourceBergen Corp. - Segment focus
12.6 Attain Med Inc.
Exhibit 123: Attain Med Inc. - Overview
Exhibit 124: Attain Med Inc. - Product / Service
Exhibit 125: Attain Med Inc. - Key offerings
12.7 Cardinal Health Inc.
Exhibit 126: Cardinal Health Inc. - Overview
Exhibit 127: Cardinal Health Inc. - Business segments
Exhibit 128: Cardinal Health Inc. - Key news
Exhibit 129: Cardinal Health Inc. - Key offerings
Exhibit 130: Cardinal Health Inc. - Segment focus
12.8 China Resources Pharmaceutical Group Ltd.
Exhibit 131: China Resources Pharmaceutical Group Ltd. - Overview
Exhibit 132: China Resources Pharmaceutical Group Ltd. - Product / Service
Exhibit 133: China Resources Pharmaceutical Group Ltd. - Key offerings
12.9 Dakota Drug Inc.
Exhibit 134: Dakota Drug Inc. - Overview
Exhibit 135: Dakota Drug Inc. - Product / Service
Exhibit 136: Dakota Drug Inc. - Key offerings
12.10 FFF Enterprises Inc.
Exhibit 137: FFF Enterprises Inc. - Overview
Exhibit 138: FFF Enterprises Inc. - Product / Service
Exhibit 139: FFF Enterprises Inc. - Key offerings
12.11 J M Smith Corp.
Exhibit 140: J M Smith Corp. - Overview
Exhibit 141: J M Smith Corp. - Product / Service
Exhibit 142: J M Smith Corp. - Key offerings
12.12 McKesson Corp.
Exhibit 143: McKesson Corp. - Overview
Exhibit 144: McKesson Corp. - Business segments
Exhibit 145: McKesson Corp. - Key offerings
Exhibit 146: McKesson Corp. - Segment focus
12.13 Medline Industries LP
Exhibit 147: Medline Industries LP - Overview
Exhibit 148: Medline Industries LP - Product / Service
Exhibit 149: Medline Industries LP - Key offerings
12.14 Owens and Minor Inc.
Exhibit 150: Owens and Minor Inc. - Overview
Exhibit 151: Owens and Minor Inc. - Business segments
Exhibit 152: Owens and Minor Inc. - Key offerings
Exhibit 153: Owens and Minor Inc. - Segment focus
12.15 PHOENIX Pharmahandel GmbH and Co KG
Exhibit 154: PHOENIX Pharmahandel GmbH and Co KG - Overview
Exhibit 155: PHOENIX Pharmahandel GmbH and Co KG - Product / Service
Exhibit 156: PHOENIX Pharmahandel GmbH and Co KG - Key news
Exhibit 157: PHOENIX Pharmahandel GmbH and Co KG - Key offerings
12.16 Shanghai Fosun Pharmaceutical Group Co. Ltd.
Exhibit 158: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Overview
Exhibit 159: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Business segments
Exhibit 160: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Key offerings
Exhibit 161: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Segment focus
12.17 SUZUKEN Co. Ltd.
Exhibit 162: SUZUKEN Co. Ltd. - Overview
Exhibit 163: SUZUKEN Co. Ltd. - Business segments
Exhibit 164: SUZUKEN Co. Ltd. - Key offerings
Exhibit 165: SUZUKEN Co. Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 166: Inclusions checklist
Exhibit 167: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 168: Currency conversion rates for US$
13.4 Research methodology
Exhibit 169: Research methodology
Exhibit 170: Validation techniques employed for market sizing
Exhibit 171: Information sources
13.5 List of abbreviations
Exhibit 172: List of abbreviations